SEC Form 4 research
| Issuer | Stoke Therapeutics, Inc. |
|---|---|
| Tickers | STOK |
| Reporting owners | 31 |
| Officers and directors | 13 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-10-02 | Allan Jonathan | S | 627 | $26.33 | Not reported |
| 2026-10-02 | 2026-10-01 | Ticho Barry | S | 1,051 | $26.16 | Not reported |
| 2026-09-25 | 2026-09-23 | Cumbo Alexander | A | 39,674 | $0 | Not reported |
| 2026-09-03 | 2026-09-01 | Ticho Barry | S | 1,600 | $31.06 | Not reported |
| 2026-09-03 | 2026-09-01 | Ticho Barry | S | 3,945 | $30.51 | Not reported |
| 2026-08-18 | 2026-08-18 | Allan Jonathan | S | 145 | $32.47 | Not reported |
| 2026-08-18 | 2026-08-18 | Allan Jonathan | S | 2,716 | $32.01 | Not reported |
| 2026-08-18 | 2026-08-18 | Ticho Barry | S | 242 | $32.47 | Not reported |
| 2026-08-18 | 2026-08-18 | Ticho Barry | S | 4,525 | $32.01 | Not reported |
| 2026-08-18 | 2026-08-18 | Kaye Edward M. MD | S | 637 | $32.47 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.